The downregulation of AR expression in the prostate cancer cells resulted in recruiting more CD4+ T cells, providing a feedback loop for this interaction between the prostate cancer cells and CD4+ T cells enforcing invasiveness of the prostate cancer. This evidence concerns the gene AR and prostate carcinoma.